CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
1.78
5.32%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.06
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.88
Open* 1.87
1-Year Change* -13.02%
Day's Range* 1.7 - 1.87
52 wk Range 1.08-2.70
Average Volume (10 days) 270.06K
Average Volume (3 months) 7.01M
Market Cap 83.16M
P/E Ratio -100.00K
Shares Outstanding 58.56M
Revenue 10.74M
EPS -0.96
Dividend (Yield %) N/A
Beta 1.20
Next Earnings Date Mar 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 4, 2024 1.78 -0.09 -4.81% 1.87 1.88 1.70
Mar 1, 2024 1.88 0.02 1.08% 1.86 1.93 1.85
Feb 29, 2024 1.89 0.00 0.00% 1.89 1.95 1.87
Feb 28, 2024 1.84 -0.12 -6.12% 1.96 1.98 1.83
Feb 27, 2024 1.98 0.00 0.00% 1.98 2.05 1.95
Feb 26, 2024 1.91 0.07 3.80% 1.84 1.92 1.83
Feb 23, 2024 1.88 0.04 2.17% 1.84 1.89 1.83
Feb 22, 2024 1.84 -0.15 -7.54% 1.99 2.01 1.83
Feb 21, 2024 1.93 0.06 3.21% 1.87 1.97 1.80
Feb 20, 2024 1.84 -0.18 -8.91% 2.02 2.08 1.79
Feb 16, 2024 1.99 0.09 4.74% 1.90 2.05 1.84
Feb 15, 2024 1.90 0.03 1.60% 1.87 1.93 1.82
Feb 14, 2024 1.89 0.06 3.28% 1.83 1.92 1.81
Feb 13, 2024 1.88 -0.05 -2.59% 1.93 1.96 1.71
Feb 12, 2024 1.95 0.07 3.72% 1.88 2.00 1.88
Feb 9, 2024 1.93 -0.02 -1.03% 1.95 2.02 1.89
Feb 8, 2024 1.93 0.30 18.40% 1.63 1.99 1.63
Feb 7, 2024 1.63 0.00 0.00% 1.63 1.64 1.61
Feb 6, 2024 1.63 -0.01 -0.61% 1.64 1.69 1.62
Feb 5, 2024 1.67 -0.07 -4.02% 1.74 1.75 1.63

aTyr Pharma Events

Time (UTC) Country Event
Thursday, March 7, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 aTyr Pharma Inc Earnings Release
Q4 2023 aTyr Pharma Inc Earnings Release

Forecast

-

Previous

-
Tuesday, May 7, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 aTyr Pharma Inc Earnings Release
Q1 2024 aTyr Pharma Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 16, 2024

Time (UTC)

16:00

Country

US

Event

aTyr Pharma Inc Annual Shareholders Meeting
aTyr Pharma Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 10.386 0 10.455 0.422 0
Total Operating Expense 56.79 34.015 26.366 23.4 32.82
Selling/General/Admin. Expenses, Total 13.982 10.751 9.075 9.352 12.435
Research & Development 42.808 23.264 17.291 14.048 20.385
Unusual Expense (Income) 0
Operating Income -46.404 -34.015 -15.911 -22.978 -32.82
Interest Income (Expense), Net Non-Operating
Net Income Before Taxes -45.343 -33.777 -16.23 -23.763 -34.515
Net Income After Taxes -45.343 -33.777 -16.23 -23.763 -34.515
Net Income Before Extra. Items -45.338 -33.768 -16.224 -23.603 -34.515
Net Income -45.338 -33.768 -16.224 -23.603 -34.515
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -45.338 -33.768 -16.224 -23.603 -34.515
Income Available to Common Incl. Extra. Items -45.338 -33.768 -16.224 -23.603 -34.515
Diluted Net Income -45.338 -33.768 -16.224 -23.603 -34.515
Diluted Weighted Average Shares 28.4196 19.0809 9.16027 3.3556 2.13979
Diluted EPS Excluding Extraordinary Items -1.59531 -1.76973 -1.77113 -7.03391 -16.1301
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -1.59531 -1.76973 -1.77113 -7.03391 -16.1301
Other, Net 1.061 0.238 -0.319 -0.785 -1.695
Total Extraordinary Items 0 0
Revenue 10.386 0 10.455 0.422
Minority Interest 0.005 0.009 0.006 0.16
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 10.386 0 0
Revenue 10.386
Total Operating Expense 13.558 12.787 18.336 13.492 12.584
Selling/General/Admin. Expenses, Total 3.718 3.408 3.426 3.625 3.449
Research & Development 9.84 9.379 14.91 9.867 9.135
Operating Income -13.558 -12.787 -7.95 -13.492 -12.584
Other, Net 1.216 0.835 0.427 0.247 0.163
Net Income Before Taxes -12.342 -11.952 -7.523 -13.245 -12.421
Net Income After Taxes -12.342 -11.952 -7.523 -13.245 -12.421
Minority Interest 0.004 0.001 0.002 0.001 0.001
Net Income Before Extra. Items -12.338 -11.951 -7.521 -13.244 -12.42
Net Income -12.338 -11.951 -7.521 -13.244 -12.42
Income Available to Common Excl. Extra. Items -12.338 -11.951 -7.521 -13.244 -12.42
Income Available to Common Incl. Extra. Items -12.338 -11.951 -7.521 -13.244 -12.42
Diluted Net Income -12.338 -11.951 -7.521 -13.244 -12.42
Diluted Weighted Average Shares 55.1438 41.8977 29.1242 28.663 28.0634
Diluted EPS Excluding Extraordinary Items -0.22374 -0.28524 -0.25824 -0.46206 -0.44257
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.22374 -0.28524 -0.25824 -0.46206 -0.44257
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 80.871 113.569 35.531 31.925 50.803
Cash and Short Term Investments 66.146 107.911 31.689 31.144 49.545
Cash & Equivalents 9.981 2.336 16.952 9.21 22.962
Short Term Investments 56.165 105.575 14.737 21.934 26.583
Prepaid Expenses 2.95 5.223 1.803 0.781 1.258
Total Assets 95.786 115.537 38.726 36.188 52.746
Property/Plant/Equipment, Total - Net 11.557 1.81 2.982 4.091 1.853
Property/Plant/Equipment, Total - Gross 17.911 7.967 9.606 10.305 7.877
Accumulated Depreciation, Total -6.354 -6.157 -6.624 -6.214 -6.024
Long Term Investments
Other Long Term Assets, Total 3.358 0.158 0.213 0.172 0.09
Total Current Liabilities 13.862 6.013 5.864 12.923 10.833
Accounts Payable 3.106 1.031 1.431 0.847 1.04
Accrued Expenses 10.492 4.982 4.433 3.131 2.026
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.264 0 8.737 7.767
Other Current Liabilities, Total 0.208
Total Liabilities 24.322 6.236 7.076 15.002 19.096
Total Long Term Debt 1.007 0 0 0 8.263
Long Term Debt 0 8.263
Other Liabilities, Total 9.633 0.398 1.378 2.239
Total Equity 71.464 109.301 31.65 21.186 33.65
Common Stock 0.029 0.028 0.011 0.004 0.031
Additional Paid-In Capital 489.502 481.832 370.21 343.524 332.378
Retained Earnings (Accumulated Deficit) -417.634 -372.296 -338.528 -322.304 -298.701
Other Equity, Total -0.433 -0.263 -0.043 -0.04 -0.06
Total Liabilities & Shareholders’ Equity 95.786 115.537 38.726 36.188 52.746
Total Common Shares Outstanding 29.4985 27.793 11.019 3.89179 2.18422
Preferred Stock - Non Redeemable, Net 0 0 0 0.002 0.002
Minority Interest -0.18 -0.175 -0.166 -0.16
Total Receivables, Net 11.775 0.435 2.039
Capital Lease Obligations 1.007
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 107.298 114.431 119.447 80.871 84.633
Cash and Short Term Investments 102.131 108.581 114.385 66.146 77.374
Cash & Equivalents 9.787 12.313 20.69 9.981 18.359
Short Term Investments 92.344 96.268 93.695 56.165 59.015
Total Receivables, Net 2.087 1.287 1.625 11.775 0.873
Prepaid Expenses 3.08 4.563 3.437 2.95 6.386
Total Assets 125.069 132.747 136.838 95.786 96.055
Property/Plant/Equipment, Total - Net 14.247 14.825 14.057 11.557 9.014
Other Long Term Assets, Total 3.524 3.491 3.334 3.358 2.408
Total Current Liabilities 12.881 12.368 13.654 13.862 11.213
Accounts Payable 2.043 0.516 3.965 3.106 3.129
Accrued Expenses 10.379 11.409 9.269 10.492 7.926
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 26.679 26.51 26.959 24.322 18.871
Total Long Term Debt 1.437 1.525 1.57 1.007 0.618
Minority Interest -0.187 -0.185 -0.181 -0.18 -0.178
Other Liabilities, Total 12.548 12.802 11.916 9.633 7.218
Total Equity 98.39 106.237 109.879 71.464 77.184
Preferred Stock - Non Redeemable, Net 0 0 0
Common Stock 0.059 0.057 0.053 0.029 0.029
Additional Paid-In Capital 551.888 548.436 539.659 489.502 487.937
Retained Earnings (Accumulated Deficit) -453.263 -441.923 -429.585 -417.634 -410.113
Other Equity, Total -0.294 -0.333 -0.248 -0.433 -0.669
Total Liabilities & Shareholders’ Equity 125.069 132.747 136.838 95.786 96.055
Total Common Shares Outstanding 58.5601 57.0462 53.3396 29.4985 29.0094
Current Port. of LT Debt/Capital Leases 0.459 0.443 0.42 0.264 0.158
Capital Lease Obligations 1.437 1.525 1.57 1.007 0.618
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -45.343 -33.777 -16.23 -23.763 -34.515
Cash From Operating Activities -41.886 -33.075 -15.301 -20.013 -31.063
Cash From Operating Activities 0.232 0.475 0.569 0.635 0.746
Non-Cash Items 4.058 2.815 2.621 2.909 4.154
Cash Interest Paid 0.054 0 0.308 1.122 1.7
Changes in Working Capital -0.833 -2.588 -2.261 0.206 -1.448
Cash From Investing Activities 47.245 -91.566 6.9 4.925 37.172
Capital Expenditures -1.641 -0.192 -0.202 -0.079 -0.594
Other Investing Cash Flow Items, Total 48.886 -91.374 7.102 5.004 37.766
Cash From Financing Activities 5.451 110.025 16.143 1.336 -4.238
Financing Cash Flow Items 0 0
Issuance (Retirement) of Stock, Net 5.517 110.025 25.226 9.336 0.429
Issuance (Retirement) of Debt, Net -0.066 0 -9.083 -8 -4.667
Net Change in Cash 10.81 -14.616 7.742 -13.752 1.871
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -11.952 -45.343 -37.82 -24.575 -12.154
Cash From Operating Activities -0.59 -41.886 -31.517 -19.236 -10.119
Cash From Operating Activities 0.08 0.232 0.193 0.144 0.081
Non-Cash Items 0.875 4.058 2.824 1.719 0.782
Changes in Working Capital 10.407 -0.833 3.286 3.476 1.172
Cash From Investing Activities -38.172 47.245 45.246 24.597 14.626
Capital Expenditures -1.246 -1.641 -0.522 -0.096 -0.043
Other Investing Cash Flow Items, Total -36.926 48.886 45.768 24.693 14.669
Cash From Financing Activities 49.496 5.451 4.533 1.52 1.481
Issuance (Retirement) of Stock, Net 49.562 5.517 4.557 1.52 1.481
Issuance (Retirement) of Debt, Net -0.066 -0.066 -0.024
Net Change in Cash 10.734 10.81 18.262 6.881 5.988
Cash Interest Paid 0.046
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Federated Hermes Global Investment Management Corp. Investment Advisor/Hedge Fund 17.8627 10189966 0 2023-06-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 14.2757 8143763 169456 2023-06-30 LOW
Stonepine Capital Management, LLC Investment Advisor/Hedge Fund 8.1114 4627224 -198498 2023-06-30 HIGH
Lytton (Laurence W) Individual Investor 7.7835 4440188 4440188 2023-02-09 HIGH
Tikvah Management LLC Hedge Fund 4.3138 2460833 0 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.0331 2300714 206457 2023-06-30 LOW
Alyeska Investment Group, L.P. Hedge Fund 3.8663 2205555 -267599 2023-06-30 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.3844 1360232 1038991 2023-06-30 LOW
Two Sigma Investments, LP Hedge Fund 1.4224 811441 532375 2023-06-30 HIGH
Schimmel (Paul R Ph.D.) Individual Investor 1.4042 801056 6000 2023-04-26 LOW
Telemetry Investments, L.L.C. Hedge Fund 1.0939 624000 131500 2022-12-31 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.0403 593474 14572 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 0.9227 526355 368700 2023-06-30 HIGH
Millennium Management LLC Hedge Fund 0.6172 352104 352104 2023-06-30 HIGH
Citadel Advisors LLC Hedge Fund 0.5611 320090 279161 2023-06-30 LOW
Numeric Investors LLC Investment Advisor/Hedge Fund 0.5381 306950 306950 2023-06-30 MED
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.487 277804 130031 2023-06-30 LOW
XTX Markets LLC Venture Capital 0.2987 170425 170425 2023-06-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2924 166808 83900 2023-06-30 LOW
Squarepoint Capital LLP Investment Advisor/Hedge Fund 0.2794 159359 147185 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

aTyr Pharma Company profile

aTyr Pharma
Industry: Biotechnology & Medical Research (NEC)

10240 Sorrento Valley Road
Suite 300
SAN DIEGO
CALIFORNIA 92121
US

Income Statement

  • Annual
  • Quarterly

News

Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

18:44, 1 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

People also watch

XRP/USD

0.65 Price
-0.810% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

66,878.10 Price
-0.990% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,123.82 Price
+0.500% 1D Chg, %
Long position overnight fee -0.0189%
Short position overnight fee 0.0107%
Overnight fee time 22:00 (UTC)
Spread 0.29

US100

18,122.60 Price
-0.480% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading